Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EARLY-PCI
ChiCTR-TNC-11001363Phase 4Completed
- Sponsor
- Renji Hospital
- Start
- May 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tissue-plasminogen activator in myocardial infarction (MI), sponsored by Renji Hospital. Primary endpoints: death, new or worsening heart failure or cardiogenic shock and 2 more. Started May 2010; status: completed.
02
Drugs
tissue-plasminogen activator
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on ChiCTR-TNC-11001363.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TNC-11001363.